Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Metabolic Disorders
 
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases
Authors: Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement 2018 English , Cost analysis, Pricing & Reimbursement
 
 
Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients
Authors: Kostev K, Lucas A, Jacob L
Affiliations: 
Publications: 
EXP CLIN ENDOCRINOL DIABETES. 2018 MAR 12.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Metabolic Disorders , Vascular disease 2018 English , Retrospective cohort analysis
 
 
LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults
Authors: "M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi"
Affiliations: EMIF group
Publications: 
Journal of Hepatology ; Volume 66, Issue 1, Supplement
Document Types: , Abstract
Countries: , UK
Condition Year Language Analysis type
, Metabolic Disorders 2017 English , Retrospective database analysis
 
 
LBP-528 – Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults
Authors: M. Alexander, K. Loomis, J. Fairburn-Beech, J. van der Lei, T. Duarte-Salles, D. Ansell, A. Pasqua, P. Rijnbeek, P. Avillach, S. Kendrick, D. Waterworth, N. Sattar, W. Alazawi
Affiliations: EMIF group
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Metabolic Disorders 2017 English , Retrospective database analysis
 
 
Trends in the Diagnosis of Vitamin D Deficiency
Authors: Emre Basatemur, MBBS, MRCPCH, a Laura Horsfall, PhD, b Louise Marston, PhD, b Greta Rait, MD, b Alastair Sutcliffe, PhDa
Affiliations: University College London
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Metabolic Disorders 2017 English , Retrospective database analysis
 
 
Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
Authors: Kostev K, Parhofen K, Dippel FW
Affiliations: 
Publications: 
Cardiovasc Endocrinol. 2017 Jun;6(2):81-85. doi: 10.1097/XCE.0000000000000098. Epub 2016 Oct 14.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Cardiovascular disease, Metabolic Disorders 2017 English , Epidemiological study
 
 
Trends in the Diagnosis of Vitamin D Deficiency
Authors: Emre Basatemur, MBBS, MRCPCH, a Laura Horsfall, PhD, b Louise Marston, PhD, b Greta Rait, MD, b Alastair Sutcliffe, PhDa
Affiliations: University College London
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Metabolic Disorders 2017 English , Retrospective database analysis
 
 
Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adults
Authors: Alexander M, Loomis K, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Ansell D, Pasqua A, Rijnbeek P, Avillach P, Kendrick S, Waterworth D, Sattar N & Alazawi W
Affiliations: EMIF group
Publications: 
Journal of Hepatology
Document Types: , Abstract, Poster
Countries: , UK
Condition Year Language Analysis type
, Metabolic Disorders 2017 English , Retrospective database analysis
 
 
Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.
Authors: Colivicchi F1, Gulizia MM2, Franzini L3, Imperoli G4, Castello L1, Aiello A1, Ripellino C5, Cataldo N5.
Affiliations: 1 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 2 Cardiology Division, Garibaldi Nesima Hospital,Catania, Italy 3 AstraZeneca S.p.A., Milan, Italy 4 Internal Medicine Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 5 IMS Health Information Solutions Italy S.r.l., Milan, Italy
Publications: 
Advances in Therapy, 2016, [Epub ahead of print].
Document Types: , Manuscript in preparation
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical+Implications+of+Switching+Lipid+Lowering+Treatment+from+Rosuvastatin+to+Other+Agents+in+Primary+Care
Condition Year Language Analysis type
, Cardiovascular disease, Metabolic Disorders 2016 English , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
 
 
Rosuvastatin: switching treatment and clinical implications in primary care.
Authors: Heiman F1, Ripellino C1, Colivicchi F2.
Affiliations: 1 IMS Health Information Solutions Italy Srl 2 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy.
Publications: 
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Cardiovascular disease, Metabolic Disorders 2016 English , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
 
 
Changes in HbA1c, Body Weight, and Systolic Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Therapy: A Primary Care Database Study
Authors: Scheerer M, Rist R, Proske O, Meng A, Kostev K
Affiliations: 
Publications: 
Diabetes Metab Syndr Obes. 2016 Oct 31;9:337-345.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Metabolic Disorders 2016 English , Database Study
 
 
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Authors: Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F.
Affiliations: 
Publications: 
Rheumatol Ther. 2016 Jun;3(1):53-75.
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition Year Language Analysis type
, Health economics, Health policy, Metabolic Disorders , Public Health 2016 English , Retrospective cohort analysis
 
 
Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Type 2 Diabetes Patients in Germany
Authors: Qiao Q, Grandy S, Ouwens M, Kostev K
Affiliations: 
Publications: 
Diabetes Metab Syndr Obes. 2016 Jun 28;9:201-5
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes, Metabolic Disorders 2016 English
 
 
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.
Authors: Kolaczynski WM, Hankins M, Ong SH, Richter H, Clemens A, Toussi M.
Affiliations: 
Publications: 
Diabetes Ther. 2016 Sep;7(3):483-96. doi: 10.1007/s13300-016-0177-8.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Metabolic Disorders 2016 English , Retrospective database analysis
 
 
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
Authors: Maina G1, Ripellino C2
Affiliations: 1 Department of Neurosciences, University of Torino, Torino, 2 CSD Medical Research S.R.L, Milan, Italy
Publications: 
Expert Opin Drug Saf. 2014 Sep;13(9):1149-54. doi: 10.1517/14740338.2014.943732. Epub 2014 Jul 18.
Document Types: , Article
Countries: , Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25036458
Condition Year Language Analysis type
, Mental health, Metabolic Disorders 2014 English , Retrospective database analysis
 
 
Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors].
Authors: Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2
Affiliations: 1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense
Publications: 
Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes, Endocrinology, Metabolic Disorders 2014 French , Retrospective database analysis
 
 
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.
Authors: Banegas JR1, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Sazova O, Perk J, Steg PG, De Backer G, Rodríguez-Artalejo F.
Affiliations: 1Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPAZ, CIBER of Epidemiology and Public Health, Madrid, Spain
Publications: 
Int J Cardiol. 2013 Jun 5;166(1):210-4. doi: 10.1016/j.ijcard.2011.10.094. Epub 2011 Nov 5
Document Types: , Article
Countries: , Europe
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22056474
Condition Year Language Analysis type
, Metabolic Disorders 2013 English , Prospective study
 
 
Gilbert's syndrome and the risk of death: a population-based cohort study.
Authors: Horsfall LJ, Nazareth I, Pereira SP & Petersen I
Affiliations: UCL Research Department of Primary Care and Population Health
Publications: 
J Gastroenterol Hepatol. 2013 Oct;28(10):1643-7. doi: 10.1111/jgh.12279.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701650
Condition Year Language Analysis type
, Hematology, Metabolic Disorders 2013 English , Retrospective database analysis
 
 
Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France
Authors: Pichetti S(1), Sermet C(1), Godman B(2,3,4), Campbell SM(5), Gustafsson LL(2).
Affiliations: IRDES(1),universités Glasgow(3), Liverpool(4), Manchester(5), Stockholm(2)
Publications: 
Appl Health Econ Health Policy. 2013 Jun;11(3):205-18.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Metabolic Disorders 2013 English
 
 
An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study.
Authors: Delemer B, Aubert JP, Nys P, Landron F, Bouée S.
Affiliations: 
Publications: 
Eur J Endocrinol. 2012 Dec;167(6):817-23. doi: 10.1530/EJE-11-1041. Epub 2012 Oct 3.
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23034782
Condition Year Language Analysis type
, Metabolic Disorders 2012 English
 
 
Severe hypertriglyceridaemia in patients treated with lipid-modifying agents.
Authors: Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4.
Affiliations: 1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4Université de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France
Publications: 
Diabetes & Metabolism Volume 38, n° 3 pages 277-279 (juin 2012)
Document Types: , Article
Countries: , Belgium, France, Germany, Italy, UK
Abstract: http://www.em-consulte.com/en/article/735594
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders , Vascular disease 2012 English , Retrospective database analysis
 
 
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA).
Authors: Pettersson B, Ambegaonkar B, Sazonov V, Martinell M, Stålhammar J, Wändell P.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
BMC Public Health. 2010 Nov 29;10:737. doi: 10.1186/1471-2458-10-737.
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21114824
Condition Year Language Analysis type
, Metabolic Disorders 2010 English , Observational study
 
 
Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimen
Authors: Desamericq G, Laforest L, Schwalm MS, Bourke A, Broquet M, Van Ganse E & Moulin P
Affiliations: Cegedim
Publications: 
ICPE 2010
Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract, Poster
Countries: , France, UK
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders , Miscellaneous 2010 English , Retrospective database analysis
 
 
Lo studio Primula in Italia.
Authors: Ambegaonkar BM1, Heiman F2, Soro M3, Sazonov V1.
Affiliations: 1 Merck and Co., Inc., Whitehouse Station, NJ, USA, 2 Cegedim Strategic Data, 3 MSD Italy
Publications: 
Care Online. CARE 6, 2009. Pag 15-16.
Document Types: , Online article
Countries: , Italy
Abstract: http://careonline.it/wp-content/uploads/2008/08/care_6_09.pdf
Condition Year Language Analysis type
, Metabolic Disorders 2009 Italian , Retrospective database analysis
 
 
Comparison of prescription patterns of statins in primary care in five European countries: results from the LIPIDE observational survey
Authors: Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al
Affiliations: 
Publications: 
ICPE/ISPE, Providence. 2009
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders 2009 English , Retrospective database analysis
 
 
Can the relationship between age and cholesterol levels indicate effectiveness of lipid lowering therapy in primary care? France, Germany, Italy and UK
Authors: Blak BT, Hards M, Maguire A & Schwalm MS
Affiliations: Cegedim
Publications: 
ISPOR Orlando, USA
Value in Health 12(3):A142-A143
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, UK
Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-ef0c58f0-1c99-3554-8596-1bce21118531
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders 2009 English , Retrospective database analysis
 
 
LDL-C goal attainment according to prescribed lipid-lowering therapy: results from the LIPIDE European survey
Authors: Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al
Affiliations: Université Paris Est, Faculté de Médecine, Créteil, France;
Publications: 
ICPE/ISPE, Providence. 2009
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders 2009 English , Retrospective database analysis
 
 
. Prise en charge des patients dyslipidémiques dans cinq pays européens: Résultats préliminaires de l’étude LIPIDE.
Authors: Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al.
Affiliations: Université Paris Est, Faculté de Médecine, Créteil, France;
Publications: 
ADELF, Paris. 2009. [French]
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Endocrinology, Metabolic Disorders 2009 English , Retrospective database analysis
 
 
Copyright 2019 IMS Health Incorporated. All rights reserved.